145 related articles for article (PubMed ID: 22971531)
1. Halofugine prevents cutaneous graft versus host disease by suppression of Th17 differentiation.
Cheng H; Tian J; Zeng L; Pan B; Li Z; Song G; Chen W; Xu K
Hematology; 2012 Sep; 17(5):261-7. PubMed ID: 22971531
[TBL] [Abstract][Full Text] [Related]
2. TH17 cells are critical for skin-specific pathological injury in acute graft-versus-host disease.
Cheng H; Tian J; Li Z; Zeng L; Pan B; Song G; Chen W; Xu K
Transplant Proc; 2012 Jun; 44(5):1412-8. PubMed ID: 22664026
[TBL] [Abstract][Full Text] [Related]
3. [An absence of donor TH17 differentiation ameliorates dermal tissue damage].
Cheng H; Song GL; Pan B; Tian J; Yan ZL; Chen W; Xu KL; Li ZY; Zeng LY
Zhonghua Yi Xue Za Zhi; 2011 Jul; 91(26):1843-6. PubMed ID: 22093788
[TBL] [Abstract][Full Text] [Related]
4. Deviated balance between Th1 and Th17 cells exacerbates acute graft-versus-host disease in mice.
Pan B; Zhang Y; Sun Y; Cheng H; Wu Y; Song G; Chen W; Zeng L; Xu K
Cytokine; 2014 Aug; 68(2):69-75. PubMed ID: 24845795
[TBL] [Abstract][Full Text] [Related]
5. The protection and therapy effects of bortezomib in murine acute graft-versus-host disease.
Li Z; Wu Q; Yan Z; Li D; Lu G; Mou W; Wu S; Pan X; Lu Q; Xu K
Transplant Proc; 2013; 45(6):2527-35. PubMed ID: 23953575
[TBL] [Abstract][Full Text] [Related]
6. Programmed death-1 pathway in host tissues ameliorates Th17/Th1-mediated experimental chronic graft-versus-host disease.
Fujiwara H; Maeda Y; Kobayashi K; Nishimori H; Matsuoka K; Fujii N; Kondo E; Tanaka T; Chen L; Azuma M; Yagita H; Tanimoto M
J Immunol; 2014 Sep; 193(5):2565-73. PubMed ID: 25080485
[TBL] [Abstract][Full Text] [Related]
7. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
Szebeni J; Wang MG; Pearson DA; Szot GL; Sykes M
Transplantation; 1994 Dec; 58(12):1385-93. PubMed ID: 7809932
[TBL] [Abstract][Full Text] [Related]
8. Halofuginone treatment reduces interleukin-17A and ameliorates features of chronic lung allograft dysfunction in a mouse orthotopic lung transplant model.
Oishi H; Martinu T; Sato M; Matsuda Y; Hirayama S; Juvet SC; Guan Z; Saito T; Cypel M; Hwang DM; Keller TL; Whitman MR; Liu M; Keshavjee S
J Heart Lung Transplant; 2016 Apr; 35(4):518-27. PubMed ID: 26787621
[TBL] [Abstract][Full Text] [Related]
9. [Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation].
Zhao J; Zhao XY; Huang XJ
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2497-502. PubMed ID: 16321278
[TBL] [Abstract][Full Text] [Related]
10. Anti-IL-12/23 p40 antibody attenuates experimental chronic graft-versus-host disease via suppression of IFN-γ/IL-17-producing cells.
Okamoto S; Fujiwara H; Nishimori H; Matsuoka K; Fujii N; Kondo E; Tanaka T; Yoshimura A; Tanimoto M; Maeda Y
J Immunol; 2015 Feb; 194(3):1357-63. PubMed ID: 25527789
[TBL] [Abstract][Full Text] [Related]
11. The identification and characteristics of IL-22-producing T cells in acute graft-versus-host disease following allogeneic bone marrow transplantation.
Zhao K; Zhao D; Huang D; Song X; Chen C; Pan B; Wu Q; Cao J; Yao Y; Zeng L; Xu K
Immunobiology; 2013 Dec; 218(12):1505-13. PubMed ID: 23816304
[TBL] [Abstract][Full Text] [Related]
12. [Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice].
Cao J; Li L; Chen C; Zeng LY; Li ZY; Pan XY; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):83-8. PubMed ID: 21429372
[TBL] [Abstract][Full Text] [Related]
13. [Significance of Th1/Th17 Imbalance in Mice with Acute Graft-versus-Host Disease].
Yao Y; Pan B; Bian YP; Xia DD; Cheng H; Song GL; Zeng LY; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1488-92. PubMed ID: 26524063
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma regulates idiopathic pneumonia syndrome, a Th17+CD4+ T-cell-mediated graft-versus-host disease.
Mauermann N; Burian J; von Garnier C; Dirnhofer S; Germano D; Schuett C; Tamm M; Bingisser R; Eriksson U; Hunziker L
Am J Respir Crit Care Med; 2008 Aug; 178(4):379-88. PubMed ID: 18511701
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-22 aggravates murine acute graft-versus-host disease by expanding effector T cell and reducing regulatory T cell.
Zhao K; Zhao D; Huang D; Yin L; Chen C; Pan B; Wu Q; Li Z; Yao Y; Shen E; Zeng L; Xu K
J Interferon Cytokine Res; 2014 Sep; 34(9):707-15. PubMed ID: 24720737
[TBL] [Abstract][Full Text] [Related]
16. Adoptive transfer of small numbers of DX5+ cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes.
Margalit M; Ilan Y; Ohana M; Safadi R; Alper R; Sherman Y; Doviner V; Rabbani E; Engelhardt D; Nagler A
Bone Marrow Transplant; 2005 Jan; 35(2):191-7. PubMed ID: 15558045
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic pneumonia syndrome in mice after allogeneic bone marrow transplantation.
Shankar G; Bryson JS; Jennings CD; Morris PE; Cohen DA
Am J Respir Cell Mol Biol; 1998 Feb; 18(2):235-42. PubMed ID: 9476911
[TBL] [Abstract][Full Text] [Related]
18. [The role of Th17 cells in early onset of mice acute graft versus host disease].
Cheng H; Zeng LY; Pan B; Song GL; Tian J; Chen C; Yan ZL; Li ZY; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2011 May; 32(5):322-5. PubMed ID: 21729601
[TBL] [Abstract][Full Text] [Related]
19. [Blockage of Th17 cells differentiation exacerbated mouse acute intestine graft-versus-host disease following allogeneic bone marrow transplantation].
Li HJ; Cheng H; Pan B; Zeng LY; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1024-7. PubMed ID: 23363796
[TBL] [Abstract][Full Text] [Related]
20. Halofuginone ameliorates autoimmune arthritis in mice by regulating the balance between Th17 and Treg cells and inhibiting osteoclastogenesis.
Park MK; Park JS; Park EM; Lim MA; Kim SM; Lee DG; Baek SY; Yang EJ; Woo JW; Lee J; Kwok SK; Kim HY; Cho ML; Park SH
Arthritis Rheumatol; 2014 May; 66(5):1195-207. PubMed ID: 24782183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
